ABIO Latest Quarter's Earnings
| Announce Date | 10/28/2022 |
| EPS Normalized Actual | $-0.16 In Line |
| EPS GAAP Actual | $-0.16 In Line |
| Revenue Actual | $0B |
| Revenue Surprise | Beat by $0M |
Upcoming Quarter's Earnings
| Announce Date | 06/30/2024 (Pre-Market) |
| EPS Normalized Estimate | $1.34259 |
| EPS GAAP Estimate | $1.34259 |
| Revenue Estimate | $0B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2008 | -13507.2 | -0 | -13507.2 | -13507.2 | 0 |
| Dec 2000 | -17236.8 | -0 | -17236.8 | -17236.8 | 0 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | -0.23 | -0.23 | 0B | NAN% | 0M |
| FQ4 2021 (Dec 2021) | -0.39389 | -0.39389 | 0B | NAN% | 0M |
| FQ3 2021 (Sep 2021) | -0.33 | -0.33 | 0B | NAN% | 0M |
| FQ2 2021 (Jun 2021) | -0.34 | -0.34 | 0B | NAN% | 0M |
| FQ1 2021 (Mar 2021) | -0.33 | -0.33 | 0B | NAN% | 0M |
| FQ4 2020 (Dec 2020) | -0.41475 | -0.41475 | 0B | NAN% | 0M |
| FQ3 2020 (Sep 2020) | -0.33 | -0.33 | 0B | NAN% | 0M |
| FQ2 2020 (Jun 2020) | -0.73 | 3.26 | 0B | NAN% | 0M |
Quarterly Estimates Summary
FQ4 Announce Date
06/30/2024 (Pre-Market)
Consensus EPS Estimates
1.34259
Consensus Revenue Estimates
0B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2024 (Oct 2024) | 1.54141 | -- | 1.54141 | 1.54141 | 0 |
| FQ3 2024 (Jul 2024) | 1.34259 | -- | 1.34259 | 1.34259 | 0 |
| FQ2 2024 (Jun 2024) | 1.34259 | -- | 1.34259 | 1.34259 | -23 |
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2024 (Oct 2024) | 0B | -- | 0B | 0B | 0 |
| FQ3 2024 (Jul 2024) | 0B | -- | 0B | 0B | 0 |
| FQ2 2024 (Jun 2024) | 0B | -- | 0B | 0B | -22 |
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
0
Revenue # of Misses
0
Revenue # of in-lines
8
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | -0.23 | -0.23 | 100% | |
| FQ4 2021 (Dec 2021) | -0.39389 | -0.39389 | 100% | |
| FQ3 2021 (Sep 2021) | -0.33 | -0.33 | 100% | |
| FQ2 2021 (Jun 2021) | -0.34 | -0.34 | 100% | |
| FQ1 2021 (Mar 2021) | -0.33 | -0.33 | 100% | |
| FQ4 2020 (Dec 2020) | -0.41475 | -0.41475 | 100% | |
| FQ3 2020 (Sep 2020) | -0.33 | -0.33 | 100% | |
| FQ2 2020 (Jun 2020) | -3.99 | -0.73 | 3.26 | -446.58% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2022 (Mar 2022) | $0B | $0B | $0M | NAN% |
| FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |
| FQ3 2021 (Sep 2021) | $0B | $0B | $0M | NAN% |
| FQ2 2021 (Jun 2021) | $0B | $0B | $0M | NAN% |
| FQ1 2021 (Mar 2021) | $0B | $0B | $0M | NAN% |
| FQ4 2020 (Dec 2020) | $0B | $0B | $0M | NAN% |
| FQ3 2020 (Sep 2020) | $0B | $0B | $0M | NAN% |
| FQ2 2020 (Jun 2020) | $0B | $0B | $0M | NAN% |
ABIO Ratings Summary
ABIO Quant Ranking
